Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Krista Roberta Verhoeft"'
Autor:
Miao Chen, Feifei Zhang, Zhaojie Lv, Yan Li, Ka-On Lam, Yuzhu Cui, Liangzhan Sun, Jiao Huang, Yongxu Jia, Krista Roberta Verhoeft, Ying Wang, Ying Tang, Shayi Wu, Yanru Qin, Xiang Lin, Xin Yuan Guan
Publikováno v:
Cancer research. 81(4)
The ubiquitous second messenger Ca2+ has long been recognized as a key regulator in cell migration. Locally confined Ca2+, in particular, is essential for building front-to-rear Ca2+ gradient, which serves to maintain the morphologic polarity require
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b40b70dc3ba9c8183373e4bb86bbef4
https://pubmed.ncbi.nlm.nih.gov/33310726
https://pubmed.ncbi.nlm.nih.gov/33310726
Autor:
Nick Ka Ming Yau, Ian C. K. Wong, Qin Ying Lim, Vivian Wai Yan Lui, Krista Roberta Verhoeft, WY Lam, Andrew Yuon Fong, Hiu Fung Leung
Publikováno v:
Current Cancer Drug Targets. 15:327-336
The anaplastic lymphoma kinase (ALK) is a druggable target for cancer therapy. By and large, the oncogenic activation of ALK in human tumors is known to occur by gene rearrangement (e.g. EML4-ALK, NMP-ALK, etc.). Clinical use of ALK inhibitors for "A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f774a8ebf25865e3f7907bc1404b68b7
https://doi.org/10.2174/1568009615666150225123712
https://doi.org/10.2174/1568009615666150225123712
Publikováno v:
Cancers of the Head & Neck. 1
Germline CYLD mutation is associated with the development of a rare inheritable syndrome, called the CYLD cutaneous syndrome. Patients with this syndrome are distinctly presented with multiple tumors in the head and neck region, which can grow in siz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf9afc7c711e8165774038da362c285c
https://doi.org/10.1186/s41199-016-0012-y
https://doi.org/10.1186/s41199-016-0012-y
Publikováno v:
Cancers of the Head & Neck
Germline CYLD mutation is associated with the development of a rare inheritable syndrome, called the CYLD cutaneous syndrome. Patients with this syndrome are distinctly presented with multiple tumors in the head and neck region, which can grow in siz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::357c1c1c97d97c3ef93b963399efb05c
https://pubmed.ncbi.nlm.nih.gov/31093340
https://pubmed.ncbi.nlm.nih.gov/31093340
Autor:
Jason Y. K. Chan, Suet-Ting Hung, Lin Jia, Michael K. F. Mak, Maria Rusan, Jeong-Sun Seo, Brigette B.Y. Ma, Pok Man Hau, Zoey Wing Yee Liu, Ka Fai To, Anthony W.H. Chan, Matthew L. Hedberg, Jong-Yeon Shin, Hoi-Lam Ngan, Peter S. Hammerman, Kevin Y. Yip, Paul B.S. Lai, Samantha Wei-Man Lun, Anthony T.C. Chan, Andrew van Hasselt, Choi-Yi Fung, Yvonne Y. Li, Sau Dan Lee, Ann Margaret V. Chang, Edwin P. Hui, Krista Roberta Verhoeft, Seong Keun Yoo, Simion I. Chiosea, Sai Wah Tsao, Woo, John K, S., Peggy P.Y. Law, Peony Hiu Yan Poon, Yvonne Y. Y. Or, Vivian Wai Yan Lui, Lin Wang, Chit Chow, Kwok Wai Lo, Jennifer R. Grandis, Marcus H. N. Law, Grace Tin-Yun Chung, Nicole G. Chau
Publikováno v:
Nature Communications
Nature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
Nature communications, vol 8, iss 1
Nature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
Nature communications, vol 8, iss 1
Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer characterized by Epstein-Barr virus (EBV) infection and dense lymphocyte infiltration. The scarcity of NPC genomic data hinders the understanding of NPC biology, disease progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94e29502624a76e9343f4e85cf2d6857
https://pubmed.ncbi.nlm.nih.gov/28098136
https://pubmed.ncbi.nlm.nih.gov/28098136
Autor:
Nick Ka Ming, Yau, Andrew Yuon, Fong, Hiu Fung, Leung, Krista Roberta, Verhoeft, Qin Ying, Lim, Wai Yip, Lam, Ian Chi Kei, Wong, Vivian Wai Yan, Lui
Publikováno v:
Current cancer drug targets. 15(4)
The anaplastic lymphoma kinase (ALK) is a druggable target for cancer therapy. By and large, the oncogenic activation of ALK in human tumors is known to occur by gene rearrangement (e.g. EML4-ALK, NMP-ALK, etc.). Clinical use of ALK inhibitors for "A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d57f1ff37f98d4f2c1b3633d6977e7c9
https://pubmed.ncbi.nlm.nih.gov/25714698
https://pubmed.ncbi.nlm.nih.gov/25714698